Biochemical markers of vascular calcification in elderly hemodialysis patients

Alvaro Osorio1, Esperanza Ortega, Jesús M Torres

  • 1Vascular Surgery Unit, Sanitas Hospital, Madrid, Spain.

Insights

Chronic kidney disease (CKD) patients on hemodialysis show altered bone metabolism markers, including higher osteoprotegerin (OPG) and osteocalcin (OC), and lower fetuin-A. These changes are linked to vascular calcification and cardiovascular risks.

Area of Science:

  • Nephrology
  • Endocrinology
  • Cardiovascular Medicine

Background:

  • Chronic kidney disease (CKD) is linked to mineral-bone metabolism disturbances, increasing vascular calcification, cardiovascular morbidity, and mortality.
  • Understanding these metabolic alterations is crucial for managing cardiovascular complications in CKD patients.

Purpose of the Study:

  • To identify specific serum markers associated with vascular calcification in elderly male and female hemodialysis CKD patients.
  • To investigate alterations in bone formation and resorption parameters in this patient population.

Main Methods:

  • Serum levels of osteoprotegerin (OPG), fetuin-A, tartrate-resistant acid phosphatase (TRACP-5b), bone-specific alkaline phosphatase (BAP), osteocalcin (OC), intact parathyroid hormone (iPTH), 25(OH)D(3), 1,25(OH)(2)D(3), calcium, and phosphorus were measured.
  • Enzyme immunoassay, immunoenzymometric assay, ELISA, immunoradiometric assay, and photometric assay were employed for sample analysis.

Main Results:

  • Elderly male and female hemodialysis CKD patients exhibited higher serum OPG, BAP, iPTH, phosphorus, and OC levels compared to controls.
  • Conversely, serum 25(OH)D(3), 1,25(OH)(2)D(3), and fetuin-A levels were lower in CKD patients.

Conclusions:

  • Bone formation and resorption parameters are significantly altered in elderly hemodialysis CKD patients.
  • Elevated OPG and OC, along with reduced fetuin-A, are associated with vascular calcification and may contribute to cardiovascular events in CKD.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...